Companies /Healthcare
Envista Holdings Corp
NYSE: NVST Medical Instruments & Supplies
$25.32
▼ $0.52 (−2.01%) today
Markets closed · 12:05am ET

Envista (NVST) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+16.09%
Avg. EPS surprise
Consecutive EPS beats
NVST vs Market · 30-day return after each reportNVSTS&P 500
−8%−4%0%−2.5%+3.5%Q2 25+0.2%+0.3%Q3 25−8.6%−2.1%Q4 25+1.2%+0.8%Q1 26−2.1%−0.3%Q2 26
−8%−4%0%Q2 25Q3 25Q4 25Q1 26Q2 26
NVST EPS Trend · estimate vs actualEstimateActual
$0.00$0.20$0.40$0.23$0.26Q2 25$0.28$0.32Q3 25$0.32$0.38Q4 25$0.31$0.36Q1 26$0.34$0.41Q2 26$0.36$0.40Q3 26
$0.00$0.20$0.40Q2 25Q4 25Q2 26
NVST Revenue Trend · estimate vs actualEstimateActual
$0$300.0M$600.0M$640.3M$682.1MQ2 25$640.8M$669.9MQ3 25$680.0M$750.6MQ4 25$680.1M$705.5MQ1 26$716.1M$730.5MQ2 26$688.7M$691.5MQ3 26
$0$300.0M$600.0MQ2 25Q4 25Q2 26

How Often Does Envista Beat Earnings Estimates?

Envista beat EPS estimates in 6 of its last 6 reported quarters, and has beaten 6 quarters in a row.

NVST quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 GAAP diluted EPS of $3.11 includes a $428.1 million non-cash realized cumulative foreign currency translation gain ($2.62 per diluted share before tax effects); adjusted results also exclude $15.6 million of tariff refunds ($0.10 per share) and a $7.6 million loss on equity investments ($0.05 per share) $0.40 est. $0.36 +12.36% $691.5M est. $688.7M +0.40%
Q2 2026 $0.41 est. $0.34 +22.13% $730.5M est. $716.1M +2.01%
Q1 2026 $0.36 est. $0.31 +14.94% $705.5M est. $680.1M +3.74%
Q4 2025 $0.38 est. $0.32 +17.65% $750.6M est. $680.0M +10.39%
Q3 2025 $0.32 est. $0.28 +15.94% $669.9M est. $640.8M +4.55%
Q2 2025 $0.26 est. $0.23 +13.54% $682.1M est. $640.3M +6.53%

Figures from SEC filings and company reports. Not investment advice.